Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Scilex Holding Company (SCLX)
USD8.84
+0.08 (+0.91%)
US NASDAQ Healthcare Drug Manufacturers - General
Address
960 San Antonio Road 94303
Palo Alto, CA, US
Palo Alto, CA, US
CEO
Henry H. Ji
Website
scilexholding.com
IPO
2021-03-05
CIK 1820190 ISIN US80880W2052
Also trades on
NASDAQ Capital Market · SCLX (USD)
NASDAQ Capital Market · VCKA (USD)
NASDAQ Capital Market · VCKAU (USD)
NASDAQ Capital Market · VCKAW (USD)
NASDAQ Global Market · SCLXW (USD)
Description
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD8.84
+0.08 (+0.91%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
134.4K
Beta
1.73
Float Shares
7.00M
Free Float %
82.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.83% | +6.57% | -4.26% | -21.12% | -68.51% | -47.50% | +32.06% | -97.08% | -98.16% | -98.14% | -98.14% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
8.84
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-10.42
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - General: +6.6%-46.5% Q1'26: +72.1% (vs Q1'25)
-
EPS growth Drug Manufacturers - General: +18.2%-87.8% Q1'26: -177.9% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - General: +36.0%-546.5% Q1'26: -48.3% (vs Q1'25)
-
EBIT margin Drug Manufacturers - General: +19.4%-900.1% Q1'26: -373.5% (vs Q1'25)
-
ROIC Drug Manufacturers - General: +10.2%— Q1'26: +85.2% (vs Q1'25)
-
Share dilution Drug Manufacturers - General: +0.0%+58.7% Q1'26: -40.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - General: -0.29×-0.50× Q1'26: -0.91× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
38.03M
est: 46.46M (-18.1%)
|
46.74M
est: 50.83M (-8.0%)
|
56.59M
est: 62.93M (-10.1%)
|
30.25M
est: 37.56M (-19.5%)
|
66.00M
66.00M – 66.00M
+75.7% YoY
|
188.97M
188.97M – 188.97M
+186.3% YoY
|
608.48M
608.48M – 608.48M
+222.0% YoY
|
944.18M
944.18M – 944.18M
+55.2% YoY
|
1.09B
1.09B – 1.09B
+15.6% YoY
|
| EBITDA |
-9.30M
est: -39.44M (+76.4%)
|
-109.10M
est: -43.15M (-152.8%)
|
-66.80M
est: -53.42M (-25.0%)
|
-267.68M
est: -31.89M (-739.5%)
|
-56.03M
-56.03M – -56.03M
-75.7% YoY
|
-160.42M
-160.42M – -160.42M
-186.3% YoY
|
-516.55M
-516.55M – -516.55M
-222.0% YoY
|
-801.53M
-801.53M – -801.53M
-55.2% YoY
|
-926.19M
-926.19M – -926.19M
-15.6% YoY
|
| EBIT |
-13.76M
est: -40.53M (+66.1%)
|
-113.25M
est: -44.34M (-155.4%)
|
-70.85M
est: -54.90M (-29.0%)
|
-272.30M
est: -32.76M (-731.1%)
|
-57.57M
-57.57M – -57.57M
-75.7% YoY
|
-164.84M
-164.84M – -164.84M
-186.3% YoY
|
-530.79M
-530.79M – -530.79M
-222.0% YoY
|
-823.64M
-823.64M – -823.64M
-55.2% YoY
|
-951.74M
-951.74M – -951.74M
-15.6% YoY
|
| Net Income |
-23.36M
est: -2.69M (-767.2%)
|
-114.33M
est: -16.47M (-594.4%)
|
-72.81M
est: -256.43M (+71.6%)
|
-358.73M
est: -402.49M (+10.9%)
|
-9.82M
-9.82M – -9.82M
+97.6% YoY
|
8.05M
8.05M – 8.05M
+182.0% YoY
|
74.81M
74.81M – 74.81M
+828.8% YoY
|
120.27M
120.27M – 120.27M
+60.8% YoY
|
138.81M
138.81M – 138.81M
+15.4% YoY
|
| SGA |
64.90M
est: 91.14M (-28.8%)
|
119.64M
est: 170.77M (-29.9%)
|
119.02M
est: 211.42M (-43.7%)
|
266.63M
est: 126.18M (+111.3%)
|
221.72M
221.72M – 221.72M
+75.7% YoY
|
634.82M
634.82M – 634.82M
+186.3% YoY
|
2.04B
2.04B – 2.04B
+222.0% YoY
|
3.17B
3.17B – 3.17B
+55.2% YoY
|
3.67B
3.67B – 3.67B
+15.6% YoY
|
| EPS |
-6.09
est: -0.39 (-1,471.4%)
|
-44.85
est: -1.49 (-2,905.5%)
|
-19.43
est: -23.24 (+16.4%)
|
-36.48
est: -32.32 (-12.9%)
|
-0.89
-0.89 – -0.89
+97.2% YoY
|
0.73
0.73 – 0.73
+182.0% YoY
|
6.78
6.78 – 6.78
+828.8% YoY
|
10.90
10.90 – 10.90
+60.8% YoY
|
12.58
12.58 – 12.58
+15.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.42M
OE per share TTM
-1.11
Owner's Yield
-21.32%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
68
Total invested
5.81M
Insider transactions (90d)
2
Beneficial owners (>5%)
2
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCLX Stock Acquisition JV LLC | 89.62M | 39.30% | 89.62M | — | 89.62M | — | OO | — | 2023-09-29 | ↗ |
| 2 | Scilex Holding Company | 500.0K | 39.90% | 500.0K | — | 500.0K | — | CO | — | 2024-09-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
68
-10 vs prev Q
New positions
8
Closed positions
18
Increased
16
Reduced
15
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 476.7K +410.7K (+622.2%) | 5.82M +4.5M (+347.7%) | 4.11% +3.539 pp | 0.07% +0.050 pp | USD13.24 -7.9% | 2 qtrs — |
| 2 | VANGUARD GROUP INC | 295.0K +12.6K (+4.5%) | 3.60M -2.0M (-35.2%) | 2.54% +0.107 pp | 0.00% +0.000 pp | USD6.16 +98.1% | 3 qtrs — |
| 3 | BLACKROCK, INC. | 98.3K -49.0 (0.0%) | 1.20M -736.5K (-38.0%) | 0.85% -0.001 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 38.5K +19.3K (+100.7%) | 469.3K +92.1K (+24.4%) | 0.33% +0.166 pp | 0.00% +0.000 pp | USD15.93 -23.4% | 2 qtrs — |
| 5 | STATE STREET CORP | 34.4K +921.0 (+2.8%) | 419.1K -238.8K (-36.3%) | 0.30% +0.008 pp | 0.00% +0.000 pp | USD14.71 -17.1% | 3 qtrs — |
| 6 | 683 CAPITAL MANAGEMENT, LLC | 27.3K +27.3K (+100.0%) | 333.2K +333.2K (+100.0%) | 0.24% +0.235 pp | 0.01% +0.015 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 7 | XTX TOPCO LTD | 20.4K +20.4K (+100.0%) | 249.4K +249.4K (+100.0%) | 0.18% +0.176 pp | 0.01% +0.007 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 8 | CITIGROUP INC | 19.8K +19.8K (+100.0%) | 242.1K +242.1K (+100.0%) | 0.17% +0.171 pp | 0.00% +0.000 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 9 | ASHTON THOMAS PRIVATE WEALTH, LLC | 18.0K +— (+0.0%) | 219.5K -134.6K (-38.0%) | 0.16% 0.000 pp | 0.01% -0.004 pp | USD19.68 -38.0% | 2 qtrs — |
| 10 | NORTHERN TRUST CORP | 15.0K -124.0 (-0.8%) | 183.4K -114.9K (-38.5%) | 0.13% -0.001 pp | 0.00% +0.000 pp | USD19.68 -38.0% | 2 qtrs — |
| 11 | MORGAN STANLEY | 14.6K -8.6K (-36.9%) | 178.2K -277.5K (-60.9%) | 0.13% -0.074 pp | 0.00% +0.000 pp | USD8.93 +36.6% | 3 qtrs — |
| 12 | OMERS ADMINISTRATION CORP | 12.3K +12.3K (+100.0%) | 150.1K +150.1K (+100.0%) | 0.11% +0.106 pp | 0.00% +0.001 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 13 | UBS GROUP AG | 11.8K -13.8K (-54.0%) | 144.0K -360.8K (-71.5%) | 0.10% -0.120 pp | 0.00% 0.000 pp | USD9.77 +24.9% | 3 qtrs — |
| 14 | QUBE RESEARCH & TECHNOLOGIES LTD | 11.6K +11.6K (+100.0%) | 141.2K +141.2K (+100.0%) | 0.10% +0.100 pp | 0.00% +0.000 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 15 | BANK OF AMERICA CORP /DE/ | 7.4K -10.0K (-57.4%) | 90.4K -251.8K (-73.6%) | 0.06% -0.086 pp | 0.00% +0.000 pp | USD12.06 +1.2% | 3 qtrs — |
| 16 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 3.1K +3.1K (+100.0%) | 38.0K +38.0K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD12.20 +0.0% | 1 qtrs NEW |
| 17 | JPMORGAN CHASE & CO | 3.0K +3.0K (+50,483.3%) | 37.0K +36.9K (+31,278.8%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD12.19 +0.1% | 3 qtrs — |
| 18 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.9K +1.8K (+172.5%) | 35.2K +14.4K (+68.9%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD14.78 -17.5% | 3 qtrs — |
| 19 | CREATIVE FINANCIAL DESIGNS INC /ADV | 1.9K +— (+0.0%) | 22.6K -13.9K (-38.0%) | 0.02% +0.000 pp | 0.00% -0.001 pp | USD19.68 -38.0% | 2 qtrs — |
| 20 | ADVISOR GROUP HOLDINGS, INC. | 1.1K +917.0 (+397.0%) | 14.0K +9.0K (+180.5%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD10.93 +11.6% | 3 qtrs — |
| 21 | JONES FINANCIAL COMPANIES LLLP | 1.1K +122.0 (+12.3%) | 13.6K -15.4K (-53.1%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD18.49 -34.0% | 3 qtrs — |
| 22 | METLIFE INVESTMENT MANAGEMENT, LLC | 1.1K +— (+0.0%) | 13.3K -8.2K (-38.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 23 | ROYAL BANK OF CANADA | 884.00 +739.0 (+509.7%) | 11.0K +8.0K (+266.7%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD11.16 +9.3% | 3 qtrs — |
| 24 | DEUTSCHE BANK AG\ | 800.00 +— (+0.0%) | 9.8K -6.0K (-38.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 25 | VERSANT CAPITAL MANAGEMENT, INC | 761.00 +— (+0.0%) | 9.3K -5.7K (-38.0%) | 0.01% +0.000 pp | 0.00% -0.001 pp | USD5.89 +107.1% | 3 qtrs — |
| 26 | MCF ADVISORS LLC | 474.00 +— (+0.0%) | 5.8K -3.5K (-38.0%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD19.68 -38.0% | 2 qtrs — |
| 27 | ACTIVEST WEALTH MANAGEMENT | 302.00 +— (+0.0%) | 3.7K -2.3K (-38.0%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD5.89 +107.1% | 3 qtrs — |
| 28 | KLP KAPITALFORVALTNING AS | 290.00 +— (+0.0%) | 3.5K -2.2K (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.25 +4,780.0% | 4 qtrs — |
| 29 | GAMMA INVESTING LLC | 126.00 -22.0 (-14.9%) | 1.5K -1.4K (-47.2%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD15.38 -20.7% | 3 qtrs — |
| 30 | WELLS FARGO & COMPANY/MN | 121.00 +18.0 (+17.5%) | 1.5K -551.0 (-27.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.82 +78.9% | 3 qtrs — |
| 31 | FORTITUDE FAMILY OFFICE, LLC | 80.00 +— (+0.0%) | 976.00 -598.0 (-38.0%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD19.68 -38.0% | 2 qtrs — |
| 32 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 44.00 +— (+0.0%) | 537.00 -329.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 33 | LARSON FINANCIAL GROUP LLC | 42.00 +— (+0.0%) | 512.00 -315.0 (-38.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.88 +107.5% | 3 qtrs — |
| 34 | RHUMBLINE ADVISERS | 35.00 +— (+0.0%) | 427.00 -261.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.86 +108.2% | 3 qtrs — |
| 35 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 29.00 +— (+0.0%) | 354.00 -217.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.86 +108.2% | 3 qtrs — |
| 36 | — | 26.00 +26.0 (+100.0%) | 317.00 +317.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.19 +0.1% | 1 qtrs NEW |
| 37 | NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 24.00 +— (+0.0%) | 293.00 -179.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.88 +107.5% | 3 qtrs — |
| 38 | NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 23.00 +— (+0.0%) | 281.00 -172.0 (-38.0%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD5.87 +107.8% | 3 qtrs — |
| 39 | DANSKE BANK A/S | 20.00 -47.0 (-70.1%) | 244.00 -1.1K (-81.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.85 +108.5% | 3 qtrs — |
| 40 | OPEROSE ADVISORS LLC | 20.00 +— (+0.0%) | 244.00 -150.0 (-38.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.85 +108.5% | 3 qtrs — |
| 41 | BNP PARIBAS ARBITRAGE, SNC | 18.00 -7.4K (-99.8%) | 220.00 -146.0K (-99.8%) | 0.00% -0.064 pp | 0.00% 0.000 pp | USD14.89 -18.1% | 3 qtrs — |
| 42 | MAI CAPITAL MANAGEMENT | 16.00 -2.0 (-11.1%) | 196.00 -159.0 (-44.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.88 +107.5% | 3 qtrs — |
| 43 | PACIFICA PARTNERS INC. | 14.00 +— (+0.0%) | 183.00 -104.0 (-36.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.64 -37.9% | 2 qtrs — |
| 44 | NEWEDGE ADVISORS, LLC | 14.00 +— (+0.0%) | 171.00 -105.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.64 -37.9% | 2 qtrs — |
| 45 | SOA WEALTH ADVISORS, LLC. | 13.00 +— (+0.0%) | 159.00 -97.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.85 +108.5% | 3 qtrs — |
| 46 | SACHETTA, LLC | 12.00 +— (+0.0%) | 147.00 -90.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.67 -38.0% | 2 qtrs — |
| 47 | CORECAP ADVISORS, LLC | 12.00 +— (+0.0%) | 146.00 -90.0 (-38.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.83 +109.3% | 3 qtrs — |
| 48 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11.00 +4.0 (+57.1%) | 134.00 -4.0 (-2.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD16.82 -27.5% | 2 qtrs — |
| 49 | STATE OF WYOMING | 9.00 +— (+0.0%) | 116.00 -71.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 50 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 9.00 +— (+0.0%) | 110.00 -67.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 51 | SBI SECURITIES CO., LTD. | 9.00 +— (+0.0%) | 110.00 -67.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.22 +5,445.5% | 4 qtrs — |
| 52 | STERLING CAPITAL MANAGEMENT LLC | 9.00 +— (+0.0%) | 110.00 -67.0 (-37.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +107.1% | 3 qtrs — |
| 53 | FMR LLC | 7.00 +— (+0.0%) | 85.00 -53.0 (-38.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.57 -37.7% | 2 qtrs — |
| 54 | TD WATERHOUSE CANADA INC. | 7.00 -8.0 (-53.3%) | 85.00 -223.0 (-72.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.86 +108.2% | 3 qtrs — |
| 55 | US BANCORP \DE\ | 7.00 -50.0 (-87.7%) | 85.00 -1.0K (-92.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD17.86 -31.7% | 3 qtrs — |
| 56 | LEGACY WEALTH MANAGMENT, LLC/ID | 6.00 +— (+0.0%) | 74.00 -45.0 (-37.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.67 -38.0% | 2 qtrs — |
| 57 | ALLWORTH FINANCIAL LP | 6.00 +— (+0.0%) | 74.00 -45.0 (-37.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.83 +109.3% | 3 qtrs — |
| 58 | ARMSTRONG ADVISORY GROUP, INC | 5.00 +— (+0.0%) | 61.00 -38.0 (-38.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.80 +110.3% | 3 qtrs — |
| 59 | EVELYN PARTNERS INVESTMENT MANAGEMENT LLP | 5.00 +— (+0.0%) | 61.00 -37.0 (-37.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.80 +110.3% | 3 qtrs — |
| 60 | GLOBAL RETIREMENT PARTNERS, LLC | 5.00 +— (+0.0%) | 61.00 -37.0 (-37.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.80 +110.3% | 3 qtrs — |
| 61 | MEASURED WEALTH PRIVATE CLIENT GROUP, LLC | 4.00 +— (+0.0%) | 49.00 -30.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.50 -37.4% | 2 qtrs — |
| 62 | PFS PARTNERS, LLC | 4.00 +— (+0.0%) | 49.00 -30.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.75 +112.2% | 3 qtrs — |
| 63 | HARBOUR INVESTMENTS, INC. | 4.00 +— (+0.0%) | 49.00 -30.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.75 +112.2% | 3 qtrs — |
| 64 | FARTHER FINANCE ADVISORS, LLC | 4.00 +2.0 (+100.0%) | 49.00 +10.0 (+25.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.75 +39.4% | 3 qtrs — |
| 65 | TIDEMARK, LLC | 4.00 +4.0 (+100.0%) | 49.00 +49.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.00 +1.7% | 1 qtrs NEW |
| 66 | GPS WEALTH STRATEGIES GROUP, LLC | 4.00 +— (+0.0%) | 49.00 -30.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.75 +112.2% | 3 qtrs — |
| 67 | CIBC PRIVATE WEALTH GROUP, LLC | 4.00 +— (+0.0%) | 49.00 -30.0 (-38.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.75 +112.2% | 3 qtrs — |
| 68 | PARALLEL ADVISORS, LLC | 3.00 -10.0 (-76.9%) | 37.00 -219.0 (-85.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD16.33 -25.3% | 3 qtrs — |
| 69 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 3.00 +3.0 (+100.0%) | 37.00 +37.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.00 +1.7% | 1 qtrs NEW |
| 70 | SAGEVIEW ADVISORY GROUP, LLC | 2.00 +2.0 (+100.0%) | 26.00 +26.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.00 +1.7% | 1 qtrs NEW |
| 71 | STEPHENS CONSULTING, LLC | 2.00 +— (+0.0%) | 25.00 -15.0 (-37.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.50 -37.4% | 2 qtrs — |
| 72 | FLAGSHIP WEALTH ADVISORS, LLC | 2.00 +— (+0.0%) | 24.00 -15.0 (-38.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.50 +121.8% | 3 qtrs — |
| 73 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 2.00 -1.0 (-33.3%) | 24.00 -35.0 (-59.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.50 +121.8% | 3 qtrs — |
| 74 | SRS CAPITAL ADVISORS, INC. | 1.00 +— (+0.0%) | 13.00 -7.0 (-35.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.00 +144.0% | 3 qtrs — |
| 75 | HOEY INVESTMENTS, INC | 1.00 +— (+0.0%) | 13.00 -7.0 (-35.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.00 +144.0% | 3 qtrs — |
| 76 | NEW YORK STATE COMMON RETIREMENT FUND | 1.00 -12.0 (-92.3%) | 10.00 -242.0 (-96.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.00 +144.0% | 3 qtrs — |
| 77 | CORNERSTONE PLANNING GROUP LLC | 1.00 -92.0 (-98.9%) | 9.00 -4.9K (-99.8%) | 0.00% -0.001 pp | 0.00% -0.001 pp | USD19.00 -35.8% | 4 qtrs — |
| 78 | BARCLAYS PLC | — -4.1K (-100.0%) | — -79.7K (-100.0%) | 0.00% -0.035 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 79 | WEALTHSPIRE ADVISORS, LLC | — -6.0 (-100.0%) | — -119.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 80 | AVION WEALTH | — -77.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 81 | JANE STREET GROUP, LLC | — -11.5K (-100.0%) | — -227.0K (-100.0%) | 0.00% -0.100 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 82 | HRT FINANCIAL LP | — -31.9K (-100.0%) | — -627.0K (-100.0%) | 0.00% -0.275 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 83 | ADVISORY SERVICES NETWORK, LLC | — -6.0 (-100.0%) | — -118.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 84 | EVERSOURCE WEALTH ADVISORS, LLC | — -28.0 (-100.0%) | — -551.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 85 | QUANTINNO CAPITAL MANAGEMENT LP | — -10.9K (-100.0%) | — -215.4K (-100.0%) | 0.00% -0.094 pp | 0.00% -0.001 pp | USD— | 3 qtrs SOLD |
| 86 | FIRST COMMAND ADVISORY SERVICES, INC. | — -2.0 (-100.0%) | — -39.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 87 | NISA INVESTMENT ADVISORS, LLC | — -12.0 (-100.0%) | — -229.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 88 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | — -174.0 (-100.0%) | — -3.4K (-100.0%) | 0.00% -0.002 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 89 | GEODE CAPITAL MANAGEMENT, LLC | — -74.1K (-100.0%) | — -1.5M (-100.0%) | 0.00% -0.639 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.02% | 225.4K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 663.1K | 0.05% |
| 3 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 5.8K | 0.30% |
| 4 | Avantis Total Equity Markets ETF 1 AVTM | 0.00% | 758.72 | 0.23% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 675.60 | 0.17% |
| 6 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 3.3K | 0.03% |
| 7 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 9.1K | 0.17% |
| 8 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.56M | 0.03% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 3.4K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.9K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.67
Bullish
Ratio by volume
0.01
Bearish
Buys
5
Sells
3
Shares acquired
240.0K
Shares disposed
20.66M
Cash buys
—
Cash sales
3.00
Net activity
-20,417,300
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Ma Stephen Hoi | Director / Officer | P-Purchase | A | Warrant (right to buy) | 650,000 | 1.20 | 780.0K | 650,000 | D | ↗ |
| 2026-04-17 | Ji Henry | Director / Officer | S-Sale | D | Warrant (right to buy) | 650,000 | 1.20 | 780.0K | 2,600,000 | D | ↗ |
| 2026-04-16 | Ji Henry | Director / Officer | P-Purchase | A | Warrant (right to buy) | 3,250,000 | 1.20 | 3.90M | 3,250,000 | D | ↗ |
| 2025-12-30 | Scilex Holding Co | 10% Owner | S-Sale | D | Common Stock | 9,657,300 | 0.54 | 5.21M | 244,445,260 | D | ↗ |
| 2025-12-29 | Scilex Holding Co | 10% Owner | S-Sale | D | Common Stock | 7,310,984 | 0.66 | 4.79M | 254,102,560 | D | ↗ |
| 2025-12-26 | Scilex Holding Co | 10% Owner | S-Sale | D | Common Stock | 3,689,016 | 0.75 | 2.77M | 261,413,544 | D | ↗ |
| 2025-10-08 | Wu Yue Alexander | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 17.58 | 351.6K | 20,000 | D | ↗ |
| 2025-10-08 | Ma Stephen Hoi | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 60,000 | 17.58 | 1.05M | 60,000 | D | ↗ |
| 2025-10-08 | Ji Henry | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 120,000 | 17.58 | 2.11M | 120,000 | D | ↗ |
| 2025-10-08 | Followwill Dorman | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 17.58 | 351.6K | 20,000 | D | ↗ |
| 2025-10-08 | Chun Jay | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,000 | 17.58 | 351.6K | 20,000 | D | ↗ |
| 2025-01-21 | SCLX Stock Acquisition JV LLC | 10% Owner | J-Other | D | Common Stock | 3,250,000 | 0.00 | 325.00 | 51,039,214 | D | ↗ |
| 2025-01-16 | SCLX Stock Acquisition JV LLC | 10% Owner | J-Other | D | Common Stock | 779,371 | 0.00 | 77.94 | 54,289,214 | D | ↗ |
| 2025-01-02 | SCLX Stock Acquisition JV LLC | 10% Owner | J-Other | D | Common Stock | 5,000,000 | 0.00 | 500.00 | 55,068,585 | D | ↗ |
| 2024-12-18 | SHAH JAISIM | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 0.46 | 13.8K | 139,333 | D | ↗ |
| 2024-12-16 | Wu Yue Alexander | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 100,000 | 0.50 | 50.5K | 100,000 | D | ↗ |
| 2024-12-16 | Followwill Dorman | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 100,000 | 0.50 | 50.5K | 100,000 | D | ↗ |
| 2024-12-16 | Chun Jay | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 100,000 | 0.50 | 50.5K | 100,000 | D | ↗ |
| 2024-10-31 | Ji Henry | Director / Officer | P-Purchase | A | Common Stock | 8,888 | 0.94 | 8.4K | 320,161 | D | ↗ |
| 2024-10-29 | SHAH JAISIM | Director / Officer | P-Purchase | A | Common Stock | 32,000 | 0.99 | 31.7K | 109,333 | D | ↗ |
| 2024-10-18 | Followwill Dorman | Director | P-Purchase | A | Common Stock | 1,000 | 0.99 | 990.00 | 2,300 | D | ↗ |
| 2024-10-18 | Chun Jay | Director | P-Purchase | A | Common Stock | 5,000 | 0.95 | 4.8K | 112,500 | D | ↗ |
| 2024-10-17 | Wu Yue Alexander | Director | P-Purchase | A | Common Stock | 20,000 | 0.95 | 19.0K | 25,000 | D | ↗ |
| 2024-10-17 | Lemus David | Director | P-Purchase | A | Common Stock | 2,000 | 0.90 | 1.8K | 2,000 | D | ↗ |
| 2024-10-17 | Ji Henry | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.97 | 9.7K | 60,070 | I | ↗ |
| 2024-10-16 | SHAH JAISIM | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 0.99 | 29.8K | 77,333 | D | ↗ |
| 2024-10-16 | Ma Stephen Hoi | Officer | P-Purchase | A | Common Stock | 6,700 | 0.97 | 6.5K | 22,840 | D | ↗ |
| 2024-08-16 | Navani Annu | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 1.23 | 307.5K | 250,000 | — | ↗ |
| 2024-07-21 | Navani Annu | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-26 | Followwill Dorman | Director | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 1,000 | 1.37 | 1.4K | 99,000 | — | ↗ |
| 2024-06-20 | Wu Yue Alexander | Director | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 5,000 | 1.41 | 7.1K | 245,000 | — | ↗ |
| 2024-06-20 | SHAH JAISIM | Director / Officer | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 14,000 | 1.73 | 24.2K | 7,880,598 | — | ↗ |
| 2024-06-20 | Ma Stephen Hoi | Officer | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 2,000 | 1.41 | 2.8K | 148,000 | — | ↗ |
| 2024-06-20 | Chun Jay | Director | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 5,000 | 1.41 | 7.1K | 245,000 | — | ↗ |
| 2024-06-18 | Ji Henry | Director / Officer | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 6,000 | 1.41 | 8.5K | 194,000 | — | ↗ |
| 2024-06-14 | SHAH JAISIM | Director / Officer | M-Exempt | D | Nonstatutory Stock Option (right to buy) | 33,333 | 1.41 | 47.0K | 166,667 | — | ↗ |
| 2024-05-17 | SHAH JAISIM | Director / Officer | P-Purchase | A | Common Stock | 56,939 | 0.92 | 52.1K | 155,882 | — | ↗ |
| 2024-05-17 | Ma Stephen Hoi | Officer | P-Purchase | A | Common Stock | 14,140 | 0.88 | 12.4K | 14,140 | — | ↗ |
| 2024-05-17 | Ji Henry | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.88 | 44.0K | 50,070 | — | ↗ |
| 2024-05-17 | Chun Jay | Director | P-Purchase | A | Common Stock | 57,500 | 0.90 | 51.6K | 102,500 | — | ↗ |
| 2024-05-16 | SHAH JAISIM | Director / Officer | P-Purchase | A | Common Stock | 83,061 | 0.84 | 69.8K | 98,943 | — | ↗ |
| 2024-03-15 | Lemus David | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2024-03-15 | Followwill Dorman | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2023-10-04 | Wu Yue Alexander | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 1.41 | 352.5K | 250,000 | — | ↗ |
| 2023-10-04 | SHAH JAISIM | Director / Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 200,000 | 1.41 | 282.0K | 200,000 | — | ↗ |
| 2023-10-04 | Ma Stephen Hoi | Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 150,000 | 1.41 | 211.5K | 150,000 | — | ↗ |
| 2023-10-04 | Ji Henry | Director / Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 200,000 | 1.41 | 282.0K | 200,000 | — | ↗ |
| 2023-10-04 | Chun Jay | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 1.41 | 352.5K | 250,000 | — | ↗ |
| 2023-09-22 | Wu Yue Alexander | Director | — | D | Nonstatutory Stock Option (right to buy) | 404,098 | 1.73 | 699.1K | 0 | — | ↗ |
| 2023-09-22 | SCLX Stock Acquisition JV LLC | 10% Owner | — | D | Warrant to Purchase Common Stock | 490,617 | 11.50 | 5.64M | 0 | — | ↗ |
| 2023-09-22 | Ma Stephen Hoi | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-22 | Ji Henry | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 305,273 | — | ↗ |
| 2023-09-22 | Chun Jay | Director | — | D | Common Stock | 0 | 0.00 | — | 45,000 | — | ↗ |
| 2023-09-21 | Sorrento Therapeutics, Inc. | 10% Owner | S-Sale | D | Warrants to Purchase Common Stock | 4,490,617 | 11.50 | 51.64M | 0 | — | ↗ |
| 2023-03-17 | Ji Henry | Director / Officer | J-Other | A | Common Stock | 2,730 | 8.60 | 23.5K | 2,730 | — | ↗ |
| 2023-01-19 | Sorrento Therapeutics, Inc. | Director | J-Other | D | Common Stock | 73,740,795 | 0.00 | — | 61,985,795 | — | ↗ |
| 2023-01-17 | Thompson Tommy G | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-17 | SHAH JAISIM | Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 1,700,000 | 0.00 | — | 1,700,000 | — | ↗ |
| 2023-01-17 | Lemus David | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-17 | Lee Tien-Li | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-17 | Ji Henry | Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 9,000,000 | 0.00 | — | 9,000,000 | — | ↗ |
| 2023-01-17 | Hamill Laura | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-17 | Followwill Dorman | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-01-17 | CZEREPAK ELIZABETH | Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2022-12-02 | Sorrento Therapeutics, Inc. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 224,841 | 0.35 | 78.9K | 4,490,617 | — | ↗ |
| 2022-11-25 | Sorrento Therapeutics, Inc. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 46,172 | 0.44 | 20.2K | 4,265,776 | — | ↗ |
| 2022-11-23 | Sorrento Therapeutics, Inc. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 442,829 | 0.40 | 175.7K | 4,219,604 | — | ↗ |
| 2022-11-22 | Sorrento Therapeutics, Inc. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 672,775 | 0.23 | 152.0K | 3,776,775 | — | ↗ |
| 2022-11-10 | Woo Pei Wei | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | Vickers Venture Fund VI Pte Ltd | Director | J-Other | D | Warrants | 578,160 | 0.00 | — | 99,000 | — | ↗ |
| 2022-11-10 | Thompson Tommy G | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-11-10 | Sorrento Therapeutics, Inc. | Director | — | D | Series A Preferred Stock | 0 | 0.00 | — | 29,057,097 | — | ↗ |
| 2022-11-10 | SHAH JAISIM | Officer | — | D | Nonstatutory Stock Option (right to buy) | 1,568,438 | 1.73 | 2.71M | — | — | ↗ |
| 2022-11-10 | Myint Steve | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | Lemus David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | Lee Tien-Li | Director | — | D | Nonstatutory Stock Option (right to buy) | 404,098 | 1.73 | 699.1K | — | — | ↗ |
| 2022-11-10 | Kaji Suneel G | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | Ji Henry | Officer | — | D | Nonstatutory Stock Option (right to buy) | 1,799,470 | 1.73 | 3.11M | — | — | ↗ |
| 2022-11-10 | Hamill Laura | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | Followwill Dorman | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-11-10 | CZEREPAK ELIZABETH | Officer | — | D | Nonstatutory Stock Option (right to buy) | 404,098 | 1.73 | 699.1K | — | — | ↗ |
| 2021-01-06 | Woo Pei Wei | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 25,000 | — | ↗ |
| 2021-01-06 | Vickers Venture Fund VI Pte Ltd | 10% Owner | — | I | Ordinary Shares | 0 | 0.00 | — | 3,054,499 | — | ↗ |
| 2021-01-06 | Myint Steve | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 25,000 | — | ↗ |
| 2021-01-06 | Kaji Suneel G | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 25,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-23.7K
Shares Outstanding
8.49M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Jaisim Shah* Former Chief Executive Officer, President and Director | 1.25M | — | — | — | — | 16.6K | 1.27M | 0.00% | ↗ |
| 2 | 2024 | Henry Ji, Ph.D. Executive Chairperson | 1.25M | — | — | — | — | 11.7K | 1.26M | 0.00% | ↗ |
| 3 | 2024 | Stephen Ma Chief Financial Officer, Senior Vice President, Secretary and Director | 600.0K | — | — | — | — | 13.8K | 613.8K | 0.00% | ↗ |
| 4 | 2023 | Henry Ji, Ph.D. Executive Chairperson | 821.5K | — | — | 33.03M | — | 64.0K | 33.92M | 97.39% | ↗ |
| 5 | 2023 | Jaisim Shah* Former Chief Executive Officer, President and Director | 917.5K | — | — | 6.40M | — | 54.0K | 7.37M | 86.83% | ↗ |
| 6 | 2023 | Stephen Ma Chief Financial Officer, Senior Vice President, Secretary and Director | 470.7K | — | — | 1.43M | — | 2.8K | 1.90M | 75.09% | ↗ |
| 7 | 2022 | Jaisim Shah Chief Executive Officer, President and Director | 773.3K | — | — | — | — | 12.4K | 785.7K | 0.00% | ↗ |
| 8 | 2022 | Henry Ji, Ph.D. Executive Chairperson | 626.5K | — | — | — | — | — | 626.5K | 0.00% | ↗ |
| 9 | 2022 | Elizabeth Czerepak Former Executive Vice President, Chief Business Officer, Chief Financial Officer and Secretary | 172.9K | 50.0K | — | — | — | — | 222.9K | 0.00% | ↗ |
| 10 | 2021 | Jaisim Shah Chief Executive Officer, President and Director | 579.3K | 290.5K | — | — | — | 11.6K | 881.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Henry H. Ji | Chief Executive Officer, President & Executive Chairman | 2M | — |
| Stephen Ma | Senior Vice President, Chief Financial Officer, Chief Operating Officer, Corporate Secretary & Director | 718.8K | male |
| Dmitri V. Lissin | Senior Vice President of Clinical Development and Medical Affairs & Interim Chief Medical Officer | 528.8K | — |
| Suresh K. Khemani | Senior Vice President, Chief Commercial Officer & GM of Scilex Pharma | 456.8K | male |
| Gigi DeGuzman | Vice President & Chief People Officer | — | female |
| Suketu D. Desai | Interim Chief Technical Officer & Senior Vice President | — | — |
ESG Rating
ESG Score History DRUG MANUFACTURERS - GENERAL
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SCLX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
